Rethinking MYC inhibition: a multi-dimensional approach to overcome cancer’s master regulator
Frontiers in Cell and Developmental Biology · 29.04.2025 · 13
DOI: 10.3389/fcell.2025.1601975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 29.04.2025. Verfasst von Jing Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, Municipal Hospital, Qingdao, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
MYC, a master regulator in oncogenesis, has long been deemed “undruggable” due to its intrinsically disordered structure. However, recent advances are overturning this view, with direct inhibitors like Omomyc (OMO-103) and PROTAC-based degraders such as WBC100 showing promising clinical progress. Complementary strategies—including BET and CDK9 inhibitors, RNA-based therapeutics, nanobodies, and engineered proteases—are expanding the therapeutic landscape. Despite challenges in specificity, toxicity, and delivery, these innovations underscore MYC’s emerging druggability. Moreover, combination therapies integrating MYC inhibitors with chemotherapy, radiotherapy, or immunotherapy demonstrate synergistic potential. This article advocates for a multi-dimensional, biomarker-guided approach to MYC targeting, emphasizing rational drug combinations and continued innovation to overcome resistance and improve outcomes in MYC-driven cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, Municipal Hospital, Qingdao, China.
- Qingdao Preschool Techers' School, Qingdao, China.
Zitieren
APA
Yu, J., Liu, D., Yuan, Y., Sun, C., & Su, Z. (2025). Rethinking MYC inhibition: a multi-dimensional approach to overcome cancer’s master regulator. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1601975
Vancouver
Yu J, Liu D, Yuan Y, Sun C, Su Z. Rethinking MYC inhibition: a multi-dimensional approach to overcome cancer’s master regulator. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1601975
BibTeX
@article{Yu2025,
author = {Yu, Jing and Liu, Dan and Yuan, Yujian and Sun, Chunxia and Su, Zihan},
title = {Rethinking MYC inhibition: a multi-dimensional approach to overcome cancer’s master regulator},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1601975}
}
EUVIMED